Predictive factors for therapeutic response to radioactive iodine therapy in pulmonary metastases from differentiated thyroid carcinoma. [PDF]
Watanabe K +5 more
europepmc +1 more source
Longitudinal evaluation of discordant symmetric dimethylarginine and creatinine as markers of glomerular filtration rate in radioiodine-treated hyperthyroid cats. [PDF]
Hardy L, Hibbert A, Tasker S, Finch NC.
europepmc +1 more source
Subglottic Stenosis After Radioactive Iodine Treatment for Graves' Disease: A Case Report. [PDF]
Ettlin C, Giger R, Jaquet Y, Tschopp S.
europepmc +1 more source
[Transient hypothyroidism after iodine radioisotope: myth or reality?].
J, Aguayo, G, Pineda
openaire +1 more source
Association of radioactive iodine treatment with survivorship symptoms and primary care utilisation in women of reproductive age with thyroid cancer: a retrospective cohort study. [PDF]
Devanarayan P, Hartman M, Partin M.
europepmc +1 more source
Advances in Transarterial Radionuclide Therapy for Hepatocellular Carcinoma and Other Liver Tumors: From Yttrium-90 Radioembolization to Emerging Lipiodol-Based Theranostic Approaches. [PDF]
Kono Y +3 more
europepmc +1 more source
Preliminary volume-based optimization of radioactive iodine dose without radioactive iodine uptake in Graves' disease. [PDF]
Keeratitanont K +5 more
europepmc +1 more source
Head-to-head comparison of [<sup>18</sup>F]-mFBG versus [<sup>123</sup>I]-MIBG in neuroblastoma: a systematic review and meta-analysis. [PDF]
Albano D +4 more
europepmc +1 more source
Prognostic Factor Analysis for Risk-Stratified Papillary Thyroid Carcinoma and Nomogram Development for Predicting Structural Incomplete Response to Radioactive Iodine Therapy in Intermediate-Risk Patients. [PDF]
Li Y, He Z, Zhao M, Zhang B.
europepmc +1 more source
Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology. [PDF]
Suzuki K +15 more
europepmc +1 more source

